Author: Binder Mascha Trepel Martin
Publisher: Informa Healthcare
ISSN: 1746-0441
Source: Expert Opinion on Drug Discovery, Vol.4, Iss.3, 2009-03, pp. : 229-241
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Function and Antagonism of &bgr;
Current Cancer Drug Targets, Vol. 9, Iss. 4, 2009-06 ,pp. :
Targeting survivin in cancer therapy
By Pennati Marzia Folini Marco Zaffaroni Nadia
Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 4, 2008-04 ,pp. :
Targeting integrins in hepatocellular carcinoma
By Wu Yanhua Qiao Xiaojing Qiao Shouyi Yu Long
Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 4, 2011-04 ,pp. :
Targeting Ubc9 for cancer therapy
By Mo Yin-Yuan Moschos Stergios J
Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 6, 2005-12 ,pp. :
Targeting AAC-11 in cancer therapy
Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 1, 2010-01 ,pp. :